CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- Open-market buys, last 90 days
- $6,396,312
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$6,396,312. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 73 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-21 | ADAR1 Capital Management, LLC 10% owner | Purchase | +331,979 | $1.66 | $551K | 7,447,000 |
| 2026-10-20 | ADAR1 Capital Management, LLC 10% owner | Purchase | +254,342 | $1.60 | $406K | 7,115,021 |
| 2026-10-19 | ADAR1 Capital Management, LLC 10% owner | Purchase | +336,528 | $1.51 | $507K | 6,860,679 |
| 2026-09-16 | Doogan Declan Director | Purchase | +53,000 | $1.92 | $102K | 55,274 |
| 2026-09-15 | Giordano Christopher Thomas CEO | Purchase | +4,850 | $1.82 | $9K | 22,174 |
| 2026-09-11 | Giordano Christopher Thomas CEO | Purchase | +6,000 | $1.88 | $11K | 17,324 |
| 2026-09-11 | STAAB THOMAS R II Chief Financial Officer | Purchase | +5,675 | $1.94 | $11K | 15,675 |
| 2026-09-03 | ADAR1 Capital Management, LLC 10% owner | Purchase | +900,000 | $1.78 | $1.6M | 6,524,151 |
| 2026-09-02 | ADAR1 Capital Management, LLC 10% owner | Purchase | +187,704 | $1.80 | $338K | 5,624,151 |
| 2026-09-01 | ADAR1 Capital Management, LLC 10% owner | Purchase | +179,058 | $1.80 | $322K | 5,436,447 |
| 2026-08-31 | ADAR1 Capital Management, LLC 10% owner | Purchase | +403,571 | $1.79 | $723K | 5,257,389 |
| 2026-08-24 | ADAR1 Capital Management, LLC 10% owner | Purchase | +107,374 | $1.75 | $188K | 4,853,818 |
| 2026-08-21 | ADAR1 Capital Management, LLC 10% owner | Purchase | +716,369 | $1.77 | $1.3M | 4,746,444 |
| 2026-08-20 | ADAR1 Capital Management, LLC 10% owner | Purchase | +202,124 | $1.78 | $360K | 4,030,075 |
| 2026-07-13 | Giordano Christopher Thomas CEO | Option exercise | +219 | $3.55 | $777 | 2,824 |
| 2026-07-13 | Giordano Christopher Thomas CEO | Option exercise | +8,500 | $5.94 | $50K | 11,324 |
| 2026-07-13 | Giordano Christopher Thomas CEO | Option exercise · Stock Option (right to buy) | −219 | 218 | ||
| 2026-07-13 | Giordano Christopher Thomas CEO | Option exercise · Stock Option (right to buy) | −8,500 | 1,241,500 | ||
| 2026-05-11 | STAAB THOMAS R II Chief Financial Officer | Grant or award | +10,000 | 10,000 | ||
| 2026-05-11 | STAAB THOMAS R II Chief Financial Officer | Grant or award · Stock Option (right to buy) | +450,000 | 450,000 |
Page 1 of 9 · 172 trades